Ecully seqens
WebMay 11, 2015 · Seqens was founded in 2003 and is based in Ecully, France. FOLLOWING DEAL Seller (S) 1 SELLER Equistone Partners Europe Limited London, United Kingdom website DESCRIPTION Equistone Partners Europe Ltd is a private equity firm that invests in small to mid-sized companies with valued from €50 to €500 million. WebFormerly Known As Novacap Ownership Status Privately Held (backing) Financing Status Private Equity-Backed Primary Industry Specialty Chemicals Other Industries Pharmaceuticals Primary Office 21 Chemin De La Sauvegarde Auvergne-Rhone-Alpes 69134 Ecully France +33 04 00 00 00 00 Seqens Timeline 2024 2024 2024 2024
Ecully seqens
Did you know?
Web21 Ecully Parc CS 33167 Ecully 69134 France +33 4 26 99 18 00 . Activities. ... Seqens to launch 3 new pure fragrance intermediates at in-cosmetics Global. Tracking extreme … WebStreet Address 233 MSB, 1300 Lefton Esplanade, Kent, Ohio 44242 Mailing Address 800 E. Summit St. Kent, OH 44242
Webwww.seqens.com SEQENS SAS - 21 chemin de la Sauvegarde, 21 Ecully Parc - CS 33167 - 69134 ECULLY Cedex – Capital Social 226 890 746.63 euros - 444 465 736 00049 … WebMar 21, 2024 · www.seqens.com SEQENS SAS - 21 chemin de la Sauvegarde, 21 Ecully Parc - CS 33167 - 69134 ECULLY Cedex – Capital Social 226 890 746.63 euros - 444 …
WebJan 19, 2011 · Seqens offers a broad portfolio of active ingredients, pharmaceutical intermediates, and specialty ingredients, develops and industrializes the most demanding molecules, and relies on its ability to innovate, develop and implement the best available technologies. Seqens was founded in 2003 and is based in Ecully, France. WebSEQENS Pharmaceutical Manufacturing Écully, Auvergne-Rhône-Alpes 27,018 followers Global leader in pharmaceutical solutions (CDMO, Generic APIs) & Specialty Ingredients (Custom manufacturing ...
WebPRESS RELEASE ECULLY, FRANCE – August 26 th, 2024. Eurazeo today announced that it has entered into exclusive discussions to sell its stake in SEQENS to funds advised by SK Capital Partners (“SK Capital”) and to the company’s existing French shareholders: Mérieux Equity Partners, Ardian and Eximium.
WebSep 6, 2024 · Seqens, based in Ecully, France, is an integrated global leader in pharmaceutical solutions and specialty ingredients. According to Marie Legatte, marketing manager, SEQENS, KELICO V® is unique because it is the only calcium sulfonate grease available in the market today that is biodegradable. The product range is formulated with … magneto triumphWebSeqens provides active Pharmaceutical Ingredient (API) and drug substance development services. We support emerging and large pharmaceutical customers in human and animal health with their pharmaceutical and biotechnology applications for complex, niche and small molecule programs through two main R&D locations in the regions of Boston and Paris. cpra recreationmagneto tremendoWebwww.seqens.com SEQENS SAS - 21 chemin de la Sauvegarde, 21 Ecully Parc - CS 33167 - 69134 ECULLY Cedex – Capital Social 226 890 746.63 euros - 444 465 736 00049 RCS Lyon - Tel : +33 (0)4 26 99 18 00 - Fax : +33 (0)4 26 99 18 38 PRESS RELEASE Ecully – March 21st SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory magnetotropicWebMar 31, 2024 · Join the SEQENS team See Our Latest Jobs 1.0 ★★★★★ Former Employee, less than 1 year ah Seqens...... Mar 31, 2024 - Sales & Marketing Manager in … magneto tropesWebApr 7, 2024 · Seqens. Siège : Ecully - 69 Industrie / Pharmaceutique - Cosmétique Offres similaires. Alternant Supply Chain Analyst H/F Seqens. Alternance Écully - 69. Alternant … magneto ttfWebSeqens is located in Écully, Rhone-Alpes, France. Who invested in Seqens? Seqens has 2 investors including Merieux Developpement and Eurazeo. When was the last funding round for Seqens? Seqens closed its last funding round on Jun 22, 2016 from a Private Equity round. Who are Seqens 's competitors? magnetotron